News (277)

Citadel's Griffin wants to know Trump's running mate before deciding to donate RE
Transcript : Intra-Cellular Therapies, Inc., Q1 2024 Earnings Call, May 07, 2024
Intra-Cellular Therapies Reports First Quarter 2024 Financial Results AQ
Transcript : Intra-Cellular Therapies, Inc. - Special Call
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder AQ
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes AQ
Intra-Cellular Therapies, Inc. Announces Executive Changes CI
Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference AQ
Transcript : Intra-Cellular Therapies, Inc., Q4 2023 Earnings Call, Feb 22, 2024
Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update AQ
Transcript : Technology One Limited - Shareholder/Analyst Call
Transcript : PJT Partners Inc., Q4 2023 Earnings Call, Feb 06, 2024
Transcript : Intra-Cellular Therapies, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 08:15 AM
Intra-Cellular Therapies to Present at the 42nd Annual J.P. Morgan Healthcare Conference AQ
Transcript : BlueScope Steel Limited - Shareholder/Analyst Call
Transcript : Intra-Cellular Therapies, Inc. Presents at UBS Biopharma Conference 2023, Nov-08-2023 11:00 AM
Transcript : Bloomin' Brands, Inc., Q3 2023 Earnings Call, Nov 03, 2023
Transcript : Intra-Cellular Therapies, Inc., Q3 2023 Earnings Call, Nov 02, 2023
Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance AQ
Chinese chip equipment makers grab market share as U.S. tightens curbs RE
Indonesia court to rule on president, VP candidates' minimum age RE
Transcript : Intra-Cellular Therapies, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 12:55 PM
China chip stocks rally after Huawei's low-key launch of new Mate 60 Pro phone RE
Transcript : Intra-Cellular Therapies, Inc., Q2 2023 Earnings Call, Aug 03, 2023
Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance AQ
Transcript : Intra-Cellular Therapies, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 02:00 PM
Transcript : Intra-Cellular Therapies, Inc., Q1 2023 Earnings Call, May 04, 2023
Intra-Cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update AQ
Intra-Cellular Therapies to Present at the 22nd Annual Needham Virtual Healthcare Conference AQ
Transcript : Intra-Cellular Therapies, Inc. - Special Call
Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features AQ
Transcript : Infratil Limited - Analyst/Investor Day
Transcript : Intra-Cellular Therapies, Inc., Q4 2022 Earnings Call, Mar 01, 2023
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update AQ
Transcript : Technology One Limited - Shareholder/Analyst Call
Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference AQ
Transcript : Intra-Cellular Therapies, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 11:15 AM
Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference AQ
Transcript : PWR Holdings Limited - Shareholder/Analyst Call
Transcript : Intra-Cellular Therapies, Inc., Q3 2022 Earnings Call, Nov 03, 2022
Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update AQ
Transcript : VEF AB, Q3 2022 Earnings Call, Oct 26, 2022
INTRA CELLULAR THERAPIES : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Form 8-K PU
Transcript : Intra-Cellular Therapies, Inc., Q2 2022 Earnings Call, Aug 09, 2022
Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update AQ
1234NextSee all

Companies (38)

NESTLÉ S.A. 276 B $
Logo Nestlé S.A.

Nestlé S.A. is the world's leading agri-food group. Net sales break down by category of products as follows: - powdered and liquid beverages (26.7%): soluble coffees (Nescafé and Starbucks brands), coffee in capsules (Nespresso), chocolate drinks (Nesqui ...

NESTLÉ S.A. 276 B $
Logo Nestlé S.A.

Nestlé S.A. is the world's leading agri-food group. Net sales break down by category of products as follows: - powdered and liquid beverages (26.7%): soluble coffees (Nescafé and Starbucks brands), coffee in capsules (Nespresso), chocolate drinks (Nesqui ...

NESTLÉ S.A. 276 B $
Logo Nestlé S.A.

Nestlé S.A. is the world's leading agri-food group. Net sales break down by category of products as follows: - powdered and liquid beverages (26.7%): soluble coffees (Nescafé and Starbucks brands), coffee in capsules (Nespresso), chocolate drinks (Nesqui ...

ALMOGIM HOLDINGS LTD 73 M $
Logo Almogim Holdings Ltd

Almogim Holdings Ltd is an Israel-based company that is active in real estate industry. The Company itself and through its subsidiaries is engaged in the initiation, construction and operation of residential real estate projects in Israel and abroad. It's ...

WEMADE PLAY CO., LTD. 76 M $
Logo Wemade Play Co., Ltd.

Wemade Play Co Ltd, formerly SundayToz Corp, is a Korea-based company mainly engaged in the development and sale of mobile games. The Company is mainly engaged in the development and sale of mobile game software such as Anipang, Aqua Story, Anipang Poker, ...

PT FORTUNE MATE INDONESIA TBK 65 M $
Logo PT Fortune Mate Indonesia Tbk

PT Fortune Mate Indonesia Tbk is an Indonesia-based company, which is engaged in real estate development. The Company’s principal activities comprise real estate, construction services, trading, and professional activity. The Company’s office and indu ...

ZHEJIANG KAN SPECIALITIES MATERIAL CO., LTD. 264 M $
Logo Zhejiang Kan Specialities Material Co., Ltd.

ZHEJIANG KAN SPECIALITIES MATERIAL CO., LTD. is a China-based company principally engaged in the manufacture and sales of special paper products and batteries. The Company primarily provides industrial mating paper products, special food packaging paper p ...

ROTSHTEIN REALESTATE LTD 148 M $
Logo Rotshtein Realestate Ltd

Rotshtein Realestate Ltd is an Israel-based construction company active in the real estate industry. The Company is engaged directly and through its subsidiaries in the initiation of residential property development and construction. The Company acquires ...

MEHADRIN LTD 135 M $
Logo Mehadrin Ltd

Mehadrin Limited is an Israel-based company. The Company is a grower, packer and marketer of citrus fruits, as well as avocados, mangos, kumquats, sharon fruits, leeches, stone fruits, grapes, potatoes, sweet potatoes, carrots and watermelons. The majorit ...

JONIX S.P.A. 3 M $
Logo JONIX S.p.A.

Jonix SpA is an Italy-based company operating in air conditioning industry. It is engaged in research, design and development of devices and systems for the sanitization and decontamination of indoor environments with the Non-Thermal Plasma technology. It ...


1234Next

Insiders

Picture Sharon Mates
Sharon Mates

Sharon L.
Mates
is the founder and currently holds the position of Chairman, President & Chief Executive Officer at ITI, Inc. (New York) since 2002.
She is also the founder and currently serves as Chairman & Chief Executive Officer at Intra-Cellular Therapies, Inc. since 2024.
Additionally, Dr. Mates was the founder and former Chairman & Chief Executive Officer at Functional Genetics, Inc. from 2000 to 2003.
She also founded Intra-Cellular Therapies, Inc. in 2013 and serves as Chairman & Chief Executive Officer.
In her current roles, Dr. Mates is a Director-Emerging Company Section at Biotechnology Innovation Organization and an Advisor at The New York City Investment Fund Manager, Inc.Dr. Mates has previously held the position of Chairman at New York Biotechnology Association, Inc. She was also the President & Director at North American Vaccine, Inc. from 1989 to 1998.
Additionally, she served as the Director-Biotechnology Institute at the University of Maryland and as a Director at Gilda's Club New York City, Inc.Dr. Mates completed her doctorate degree from the University of Washington in 1981 and holds an undergraduate degree from The Ohio State University.


Picture Adi Zackai Mates
Adi Zackai Mates

Adi Zackai Mates is currently working as Vice President-Human Resources at Perion Network Ltd.
Previously, Adi worked as Head-Human Resources Business Partner at Amdocs, Inc. Adi holds an MBA degree from The College of Management Academic Studies.


Picture Michael John Mates
Michael John Mates

Michael John Mates is currently a Member of the Privy Council Office and a Member of The Conservative Party.
Previously, he served as a Lieutenant Colonel in the United Kingdom Army from 1954 to 1974 and as a Member of the House of Commons from 1974 to 2010.
He obtained an undergraduate degree from King's College, Cambridge.


Picture Joshua O. Mates
Joshua O. Mates

Joshua O.
Mates
is currently working as an Associate at Cooley LLP.



Picture Harper Mates
Harper Mates

Harper Gould Mates is currently the Director at Crisis Prevention Institute, Inc. She is also the Managing Director at Wendel North America and a Member-Supervisory Board at Wendel SE.
Previously, she worked as an Analyst at J.P.
Morgan & Co., Inc. (Old), a Vice President at MidOcean US Advisor LP, and an Associate at Citigroup Private Equity LP.
Ms. Mates completed her undergraduate degree at the University of Wisconsin and holds an MBA from Harvard Business School.



Picture Christopher Mates
Christopher Mates

Chris Mates is the CLO and CCO, managing the legal and compliance affairs of Disruptive and its Registered Investment Adviser and Broker Dealer affiliates.
He is an attorney with over 25 years of experience working in the financial regulatory environment focusing on the rules and regulations of the SEC, FINRA, CFTC, NFA, State regulators, and various securities and derivatives Exchanges.
He holds a B.S.
in Business Administration from Miami University, an M.B.A.
from Xavier University, a J.D.
from Chicago-Kent College of Law and holds Series 3, 4, 7, 8, 15, 24, 27, 63, 79, and 99 registrations.



No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW